Principal Investigator: Dr Brent Richards
Department: Lady Davis Institute, Medicine
- Dr Douglas Kiel
- Dr Fernando Rivadeneira
Collaborating Institutions and Addresses
- Hebrew SeniorLife, Institute for Ageing Research, 1200 Center Street, Boston MA 02131, United States
- Erasmus MC, Internal Medicine, Romm Ee5.79, ‘s-Gravendijkwal 230, Rotterdam 3015 CE, Netherlands
1a: We aim to identify genetic determinants of bone mineral density and fractures. Fractures are a common and costly medical problem, which are partially heritable. Understanding the genetic determinants of fracture will help us to understand what causes fracture.
1b: Our project meets the UK Biobank’s aim of improving the prevention, diagnosis and treatment of serious and life threatening illnesses. The proposed study aims to better understand the pathophysiologic mechanisms which lead to fracture, by determining the genetic variants that predispose to fracture and low bone mineral density. Low bone mineral density is a clinically useful predictor of fracture and most of the genetic determinants for fracture identified to date also influence bone density.
1c: We propose to undertake a genome-wide association study of individuals in the UKBiobank who have had heel bone density measured, as well as, a genome-wide association study of fracture, using as cases individuals who have reported a bone fracture within the past five years and control individuals who have not reported a bone fracture within the past five years. Briefly, we will undertake an additive allelic association test between each single nucleotide polymorphism and these two traits (bone density and fracture)
1d: We request the full cohort.